Publication | Closed Access

Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia: A Study in Nagasaki Prefecture, Japan

Hematological MalignancyChromatinPractical SettingChromatin RemodelingNagasaki PrefectureMedicineHematologyMyeloid NeoplasiaPathologyCytogenetic ResponsesMolecular DiagnosticsRadiation OncologyOncologyCell BiologyCancer ResearchHealth Sciences